Evidence map›Paper›PMID 32253701›Full record

ArticleNeuroinformatics2020

Computing Univariate Neurodegenerative Biomarkers with Volumetric Optimal Transportation: A Pilot Study.

Yanshuai Tu, Liang Mi, Wen Zhang, Haomeng Zhang, Junwei Zhang, Yonghui Fan, Dhruman Goradia, Kewei Chen, Richard J Caselli, Eric M Reiman and 3 more

Abstract read
In one paragraph

Article in Neuroinformatics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Characterizing visual cortical magnification with topological smoothing and optimal transportation.Proceedings of SPIE--the International Society for Optical Engineering · 2023
    Article
  3. Cortical Surface Shape Analysis Based on Alexandrov Polyhedra.Proceedings. IEEE International Conference on Computer Vision · 2021
    Article
  4. Cortical Morphometry Analysis based on Worst Transportation Theory.Information processing in medical imaging : proceedings of the ... conference · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Yanshuai TuSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA.
Liang MiSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA.
Wen ZhangSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA.
Haomeng ZhangSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA.
Junwei ZhangDepartment of Computer Science, Stony Brook University, Stony Brook, NY, USA.
Yonghui FanSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA.
Dhruman GoradiaBanner Alzheimer's Institute, Phoenix, AZ, USA.
Kewei ChenBanner Alzheimer's Institute, Phoenix, AZ, USA.
Richard J CaselliDepartment of Neurology, Mayo Clinic Arizona, Scottsdale, AZ, USA.
Eric M ReimanBanner Alzheimer's Institute, Phoenix, AZ, USA.
Xianfeng GuDepartment of Computer Science, Stony Brook University, Stony Brook, NY, USA.
Yalin WangSchool of Computing, Informatics, and Decision Systems Engineering, Arizona State University, P.O. Box 878809, Tempe, AZ, 85287, USA. ylwang@asu.edu.
Alzheimer’s Disease Neuroimaging Initiative

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
Research Education ComponentP30AG019610 · NIA · SUN HEALTH RESEARCH INSTITUTE · PI REIMAN, ERIC MICHAEL · 2001 to 2020
$32.5M
PET, APOE & the Preclinical Course of Alzheimer's DiseaseR01AG031581 · NIA · BANNER ALZHEIMER'S INSTITUTE · PI CASELLI, RICHARD J., REIMAN, ERIC MICHAEL · 2008 to 2018
$16.6M
Training U54EB020403 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI THOMPSON, PAUL M · 2014 to 2018
$10.1M
SVRIII: Brain Connectome and Neurodevelopment OutcomesR01HL128818 · NHLBI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI PANIGRAHY, ASHOK · 2015 to 2019
$3.5M
Multi-Source Sparse Learning to Identify MCI and Predict DeclineRF1AG051710 · NIA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI THOMPSON, PAUL M, WANG, YALIN · 2016 to 2016
$2.8M
Predicting the early childhood outcomes of preterm brain shape abnormalitiesR01EB025032 · NIBIB · CHILDREN'S HOSPITAL OF LOS ANGELES · PI LEPORE, NATASHA · 2017 to 2020
$2.6M
MRI Biomarker Discovery for Preclinical Alzheimers Disease with Geometry MethodsR21AG043760 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, YALIN · 2013 to 2014
$409k
Empowering Diffusion MRI Measures by Integrating White and Grey Matter MorphologyR21AG049216 · NIA · ARIZONA STATE UNIVERSITY-TEMPE CAMPUS · PI WANG, YALIN · 2015 to 2016
$381k
NHLBI NIH HHS R01 HL128818NIA NIH HHS P30 AG019610NIA NIH HHS R01 AG031581NIA NIH HHS R21 AG043760NIA NIH HHS R21 AG049216NIA NIH HHS RF1 AG051710NIA NIH HHS U01 AG024904NIBIB NIH HHS R01 EB025032NIBIB NIH HHS U54 EB020403
6 · The paper itself

Abstract

Changes in cognitive performance due to neurodegenerative diseases such as Alzheimer's disease (AD) are closely correlated to the brain structure alteration. A univariate and personalized neurodegenerative biomarker with strong statistical power based on magnetic resonance imaging (MRI) will benefit clinical diagnosis and prognosis of neurodegenerative diseases. However, few biomarkers of this type have been developed, especially those that are robust to image noise and applicable to clinical analyses. In this paper, we introduce a variational framework to compute optimal transportation (OT) on brain structural MRI volumes and develop a univariate neuroimaging index based on OT to quantify neurodegenerative alterations. Specifically, we compute the OT from each image to a template and measure the Wasserstein distance between them. The obtained Wasserstein distance, Wasserstein Index (WI) for short to specify the distance to a template, is concise, informative and robust to random noise. Comparing to the popular linear programming-based OT computation method, our framework makes use of Newton's method, which makes it possible to compute WI in large-scale datasets. Experimental results, on 314 subjects (140 Aβ + AD and 174 Aβ- normal controls) from the Alzheimer's Disease Neuroimaging Initiative (ADNI) baseline dataset, provide preliminary evidence that the proposed WI is correlated with a clinical cognitive measure (the Mini-Mental State Examination (MMSE) score), and it is able to identify group difference and achieve a good classification accuracy, outperforming two other popular univariate indices including hippocampal volume and entorhinal cortex thickness. The current pilot work suggests the application of WI as a potential univariate neurodegenerative biomarker.

Indexed as

AgedAlgorithmsAlzheimer DiseaseBrainFemaleHumansImage Interpretation, Computer-AssistedMagnetic Resonance ImagingMaleNeuroimagingPilot ProjectsAlzheimer’s diseaseNeurodegenerative biomarkerOptimal transportWasserstein distance

Identifiers

PMID32253701
PMCPMC7502473

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.